0001140361-16-063186.txt : 20160504
0001140361-16-063186.hdr.sgml : 20160504
20160504101151
ACCESSION NUMBER: 0001140361-16-063186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160429
FILED AS OF DATE: 20160504
DATE AS OF CHANGE: 20160504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 161617786
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
4
1
doc1.xml
FORM 4
X0306
4
2016-04-29
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
1
1
0
0
Chief Executive Officer
Common Stock
2016-04-29
2016-04-29
4
A
0
414
51.264
A
395635
D
Common Stock
2016-05-02
2016-05-02
4
M
0
36500
12.99
A
432135
D
Common Stock
2016-05-02
2016-05-02
4
S
0
36500
85.0118
D
395635
D
Common Stock
25758
I
Shares held by Bienaime Family Trust
Stock Option (right to buy) Common Stock
12.99
2016-05-02
2016-05-02
4
M
0
36500
0
D
2006-11-11
2016-05-10
Common Stock
36500
0
D
The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2015 to April 30, 2016.
Transaction made pursuant to a Rule 10b5-1 trading plan executed on August 17, 2015.
The price in column 4 is a weighted average price. The price actually received ranged from $83.94 to $86.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2016-05-04